Letters to the Editor

Rituximab, Dexamethasone, Etoposide, Ifosfamide and Carboplatin (R-DeVIC) in relapsed or refractory central nervous system lymphoma – a retrospective multicentre clinical study

Department of Hematology, Oncology, Stem-Cell Transplantation and Palliative Care, Klinikum Stuttgart, Stuttgart
Department of Hematology and Medical Oncology, Georg-August University Göttingen
Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg
Department of Hematology, Oncology, Stem-Cell Transplantation and Palliative Care, Klinikum Stuttgart, Stuttgart
Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster
Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster
Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg
Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster
Department of Hematology and Medical Oncology, Georg-August University Göttingen
Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg
Stuttgart Cancer Center – Tumorzentrum Eva Mayr-Stihl, Klinikum Stuttgart, Stuttgart
Stuttgart Cancer Center – Tumorzentrum Eva Mayr-Stihl, Klinikum Stuttgart, Stuttgart
Department of Hematology, Oncology, Stem-Cell Transplantation and Palliative Care, Klinikum Stuttgart, Stuttgart
Department of Hematology, Oncology, Stem-Cell Transplantation and Palliative Care, Klinikum Stuttgart, Stuttgart
Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg
Haematologica Early view Dec 11, 2025 https://doi.org/10.3324/haematol.2025.287982